Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

[1]  A. Kerstan,et al.  Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. , 2012, The Journal of allergy and clinical immunology.

[2]  A. Órfão,et al.  Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms , 2011, International Archives of Allergy and Immunology.

[3]  A. Órfão,et al.  Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. , 2010, The Journal of allergy and clinical immunology.

[4]  G. Passalacqua,et al.  Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. , 2009, The Journal of allergy and clinical immunology.

[5]  A. Órfão,et al.  KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. , 2006, Blood.

[6]  A. Órfão,et al.  Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA) , 2004, Cytometry. Part B, Clinical cytometry.

[7]  A. Órfão,et al.  Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. , 1996, The American journal of pathology.